close

Blogs > Health Care and Life Sciences Law Blog

New York

Jun 25, 2019

Whistleblower Complaints Resulting in Increased MFCU Investigations

Considering the significant financial incentives and awards provided to whistleblowers, it should come as no surprise that there has been a marked increase in the number of health care fraud investigations commenced by federal and state agencies.  The New York State Medicaid Fraud Control Unit (“MFCU”) is one such agency and is increasingly worthy of the attention of health care practitioners who treat Medicaid patients in the state. » Read More

Jan 31, 2019

Lawsuits Allege Oxycontin Manufacturers Mislead the Public About Addiction Risk

There can be no doubt that the dominant and most oft-debated legal issue affecting the practice of medicine today is the prescribing of controlled substances to patients for pain. At the forefront of the debate is the drug Oxycontin, a powerful opioid produced by the privately-held company Purdue Pharma.» Read More

Want to receive these blogs in an email? Subscribe here:

Categories